LAC Med set to list on Bursa with an AI healthcare play across Malaysia and Indonesia
Group’s proposed listing will serve as a springboard to accelerate regional expansion, with Indonesia as the sole overseas focus for now
[KUALA LUMPUR] As hospitals across Malaysia ramp up spending on advanced imaging, digital health and artificial intelligence (AI)-enabled diagnostics, LAC Med is preparing to list to capture the next wave of demand at home and in Indonesia.
Formerly known as LAC Medical, the medical devices and integrated healthcare technology group will mark its debut on Bursa Malaysia on Wednesday (Dec 10) following a nearly 13 times oversubscription of its public tranche.
Priced at 75 sen per share, the initial public offering will raise about RM78 million (S$24.6 million), comprising RM55.7 million in new funds for the group and RM22.5 million in proceeds for existing shareholders.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
